Riomet Related Clinical Trials
A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Metformin [Completed]
Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers [Terminated]
A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets [Completed]
Reducing Antipsychotic-Induced Weight Gain in Children With Metformin [Recruiting]
Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants [Completed]
Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets [Withdrawn]
An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients [Active, not recruiting]
Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy Volunteers [Completed]
Metformin And Chloroquine in IDH1/2-mutated Solid Tumors [Not yet recruiting]
Metformin for the Treatment of Endometrial Hyperplasia [Recruiting]
Study of Metformin With Simvastatin for Men With Prostate Carcinoma [Withdrawn]
A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer [Recruiting]
Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg [Completed]
Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg [Completed]
A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095) [Completed]
Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers [Terminated]
Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients [Active, not recruiting]
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN) [Completed]
Metformin in Non Small Cell Lung Cancer (NSCLC) [Recruiting]
Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes [Completed]
Drug-Drug Interaction Study With Metformin and Nizatidine [Completed]
The Metformin-FMD Trial [Completed]
Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus [Completed]
Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma [Recruiting]
Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth [Terminated]
Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg [Completed]
An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes [Terminated]
Safety of Continuing Metformin in Diabetic Patients With Normal Kidney Function Receiving Contrast Media [Completed]
Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) [Terminated]
Spironolactone Plus Metformin in Polycystic Ovary Syndrome [Completed]
Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121) [Completed]
Metformin-Dipyridamole Interaction Trial [Completed]
Evaluating of Pharmacokinetic Profile of BCWP_C001 and Co-administration of Rosuvastatin and Metformin [Not yet recruiting]
Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered [Completed]
Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate [Recruiting]
Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) [Recruiting]
Bioequivalence Study for Acarbose / Metformin FDC [Completed]
A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy Participants [Completed]
Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM [Completed]
Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients [Active, not recruiting]
Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes (CONSENT) [Recruiting]
Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy [Not yet recruiting]
Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B) [Completed]
Metformin in Stage IV Lung Adenocarcinoma [Recruiting]
The Drug-drug Interaction of SHR3824 and Metformin [Completed]
Metformin for the Prevention of the Metabolic Side-effects of Zyprexa [Completed]
Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313) [Completed]
Efficacy and Safety of Alogliptin and Metformin Fixed-dose Combination in Patients With Type 2 Diabetes [Active, not recruiting]
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk [Recruiting]
Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil [Completed]
PCOS Treatment Using DLBS3233, Metformin, and Combination of Both [Recruiting]
Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin [Completed]
Bioequivalence of a Medium, Fixed Dose Combination Tablet of Linagliptin/Metformin Extended Release in Healthy Subjects. [Completed]
Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A) [Completed]
Metformin for the Treatment of Unexplained Oligozspermia [Recruiting]
Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit [Not yet recruiting]
Exercise and Metformin in Colorectal and Breast Cancer Survivors [Recruiting]
Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single Tablets [Completed]
Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia [Recruiting]
Metformin in Amnestic Mild Cognitive Impairment [Completed]
Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer [Recruiting]
Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity [Not yet recruiting]
Metformin in Obese Children and Adolescents [Recruiting]
Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /Metformin [Completed]
Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers [Completed]
Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control [Completed]
Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects [Completed]
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR [Completed]
An Endometrial Cancer Chemoprevention Study of Metformin [Recruiting]
Effect of Metformin on Breast Cancer Metabolism [Completed]
Drug-drug Interaction Study With Metformin and Imatinib [Completed]
Testosterone, Metformin, or Both, for Hypogonadism in Obese Males [Recruiting]
Bioequivalence of a Low, Fixed Dose Combination Tablet of Linagliptin/Metformin Extended Release in Healthy Subjects [Completed]
Lapatinib With Sirolimus or Metformin [Active, not recruiting]
Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus. [Completed]
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer [Not yet recruiting]
A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants [Completed]
Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer (METCAP). [Recruiting]
Bioequivalence of a High, Fixed Dose Combination Tablet of Linagliptin/Metformin Extended Release in Healthy Subjects [Completed]
Metformin And Longevity [Not yet recruiting]
Gene Expression Profiles and Metformin Efficacy in Type 2 Diabetes [Not yet recruiting]
Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release Tablet [Completed]
Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary Syndrome [Completed]
Metabolic Effects of a Caloric Restriction High/Low Glycemic Index Diet Plus Metformin in Overweight/Obese Subjects [Completed]
Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) [Recruiting]
Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study [Completed]
Metformin in the Diastolic Dysfunction of Metabolic Syndrome [Recruiting]
A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib [Completed]
Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single Tablets [Completed]
Metformin and Congenital Nephrogenic Diabetes Insipidus [Not yet recruiting]
Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection [Recruiting]
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer [Recruiting]
Study to Evaluate the Safety and Efficacy of the Addition of MK-3102 Compared With the Addition of Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026) [Completed]
[Active, not recruiting]
Metformin and Longevity Genes in Prediabetes [Completed]
Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy [Completed]
|